Skip to main content
Erschienen in: International Journal of Hematology 6/2016

25.08.2016 | Original Article

Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions

verfasst von: Yasunori Matsunari, Mitsuhiko Sugimoto, Masaaki Doi, Hideto Matsui, Masahiko Kawaguchi

Erschienen in: International Journal of Hematology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Von Willebrand factor (VWF) plays an important role in mediating platelet adhesion and aggregation under high shear rate conditions. Such platelet aggregates are strengthened by fibrin-network formation triggered by tissue factor (TF). However, little is known about the role of TF in VWF-dependent thrombus formation under blood flow conditions. We evaluated TF in thrombus formation on immobilized VWF under whole blood flow conditions in an in vitro perfusion chamber system. Surface-immobilized TF amplified intra-thrombus fibrin generation significantly under both low and high shear flow conditions, while TF in sample blood showed no appreciable effects. Furthermore, immobilized TF enhanced VWF-dependent platelet adhesion and aggregation significantly under high shear rates. Neutrophil cathepsin G and elastase increased significantly intra-thrombus fibrin deposition on immobilized VWF–TF complex, suggesting the involvement of leukocyte inflammatory responses in VWF/TF-dependent mural thrombogenesis under these flow conditions. These results reveal a functional link between VWF and TF under whole blood flow conditions, in which surface-immobilized TF and VWF mutually contribute to mural thrombus formation, which is essential for normal hemostasis. By contrast, TF circulating in blood may be involved in systemic hypercoagulability, as seen in sepsis caused by severe microbial infection, in which neutrophil inflammatory responses may be active.
Literatur
1.
Zurück zum Zitat Sixma JJ, Waster J. The hemostatic plug. Semin Hematol. 1977;14:265–99.PubMed Sixma JJ, Waster J. The hemostatic plug. Semin Hematol. 1977;14:265–99.PubMed
2.
3.
Zurück zum Zitat Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112:3555–62.CrossRefPubMed Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112:3555–62.CrossRefPubMed
4.
Zurück zum Zitat Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242–50.CrossRefPubMed Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242–50.CrossRefPubMed
5.
Zurück zum Zitat Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310–8.CrossRefPubMed Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310–8.CrossRefPubMed
6.
Zurück zum Zitat Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525–41.PubMed Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88:1525–41.PubMed
7.
Zurück zum Zitat Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289–97.CrossRefPubMed Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289–97.CrossRefPubMed
8.
Zurück zum Zitat Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657–66.CrossRefPubMed Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94:657–66.CrossRefPubMed
9.
Zurück zum Zitat Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med. 2005;15(3):86–92.CrossRefPubMed Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med. 2005;15(3):86–92.CrossRefPubMed
10.
Zurück zum Zitat Fogelson AL, Tania N. Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb. 2005;34:91–108.CrossRefPubMed Fogelson AL, Tania N. Coagulation under flow: the influence of flow-mediated transport on the initiation and inhibition of coagulation. Pathophysiol Haemost Thromb. 2005;34:91–108.CrossRefPubMed
11.
Zurück zum Zitat Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;26:1729–37.CrossRefPubMed Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006;26:1729–37.CrossRefPubMed
12.
Zurück zum Zitat Mizuno T, Sugimoto M, Matsui H, Hamada M, Shida Y, Yoshioka A. Visual evaluation of blood coagulation during mural thrombogenesis under high shear flow. Thromb Res. 2008;121:855–64.CrossRefPubMed Mizuno T, Sugimoto M, Matsui H, Hamada M, Shida Y, Yoshioka A. Visual evaluation of blood coagulation during mural thrombogenesis under high shear flow. Thromb Res. 2008;121:855–64.CrossRefPubMed
13.
Zurück zum Zitat Shen F, Kastrup CJ, Liu Y, Ismagilov RF. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler Thromb Vasc Biol. 2008;28:2035–41.CrossRefPubMed Shen F, Kastrup CJ, Liu Y, Ismagilov RF. Threshold response of initiation of blood coagulation by tissue factor in patterned microfluidic capillaries is controlled by shear rate. Arterioscler Thromb Vasc Biol. 2008;28:2035–41.CrossRefPubMed
14.
Zurück zum Zitat Neeves KB, McCarty OJT, Reininger AJ, Sugimoto M, King MR. Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH. J Thromb Haemost. 2014;12:418–20.CrossRefPubMed Neeves KB, McCarty OJT, Reininger AJ, Sugimoto M, King MR. Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH. J Thromb Haemost. 2014;12:418–20.CrossRefPubMed
15.
Zurück zum Zitat Gemmell CH, Turitto VT, Nemerson Y. Flow as a regulator of the activation of factor-X by tissue factor. Blood. 1988;72:1404–6.PubMed Gemmell CH, Turitto VT, Nemerson Y. Flow as a regulator of the activation of factor-X by tissue factor. Blood. 1988;72:1404–6.PubMed
16.
Zurück zum Zitat Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 2008;111:3507–13.CrossRefPubMedPubMedCentral Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 2008;111:3507–13.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Morrissey JH. Tissue Factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004;79:103–8.CrossRefPubMed Morrissey JH. Tissue Factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004;79:103–8.CrossRefPubMed
18.
Zurück zum Zitat Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1:1335–42.CrossRefPubMed Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1:1335–42.CrossRefPubMed
19.
Zurück zum Zitat Doi M, Sugimoto M, Matsui H, Matsunari Y, Shima M. Coagulation potential of immobilized factor VIII in flow-dependent fibrin generation on platelet surfaces. Thromb Haemost. 2013;110:316–22.CrossRefPubMed Doi M, Sugimoto M, Matsui H, Matsunari Y, Shima M. Coagulation potential of immobilized factor VIII in flow-dependent fibrin generation on platelet surfaces. Thromb Haemost. 2013;110:316–22.CrossRefPubMed
20.
Zurück zum Zitat Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem. 1991;266:18172–8.PubMed Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem. 1991;266:18172–8.PubMed
21.
Zurück zum Zitat Hamada M, Sugimoto M, Matsui H, Mizuno T, Shida Y, Doi M, et al. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. Thromb Haemost. 2011;105:313–20.CrossRefPubMed Hamada M, Sugimoto M, Matsui H, Mizuno T, Shida Y, Doi M, et al. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. Thromb Haemost. 2011;105:313–20.CrossRefPubMed
22.
Zurück zum Zitat Kuwahara M, Sugimoto M, Tsuji S, Miyata S, Yoshioka A. Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions. Blood. 1999;94:1149–55.PubMed Kuwahara M, Sugimoto M, Tsuji S, Miyata S, Yoshioka A. Cytosolic calcium changes in a process of platelet adhesion and cohesion on a von Willebrand factor-coated surface under flow conditions. Blood. 1999;94:1149–55.PubMed
23.
Zurück zum Zitat Matsui H, Sugimoto M, Mizuno T, Tsuji S, Miyata S, Matsuda M, et al. Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood. 2002;100:3604–10.CrossRefPubMed Matsui H, Sugimoto M, Mizuno T, Tsuji S, Miyata S, Matsuda M, et al. Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood. 2002;100:3604–10.CrossRefPubMed
24.
Zurück zum Zitat Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood. 2003;101:915–20.CrossRefPubMed Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood. 2003;101:915–20.CrossRefPubMed
25.
Zurück zum Zitat Shida Y, Nishio K, Sugimoto M, Mizuno T, Hamada M, Kato S, et al. Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood. 2008;111:1295–8.CrossRefPubMed Shida Y, Nishio K, Sugimoto M, Mizuno T, Hamada M, Kato S, et al. Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood. 2008;111:1295–8.CrossRefPubMed
26.
Zurück zum Zitat Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94:968–75.PubMed Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94:968–75.PubMed
27.
Zurück zum Zitat Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.CrossRefPubMed Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.CrossRefPubMed
28.
Zurück zum Zitat Sugimoto M, Miyata S. Functional property under flowing blood. Int J Hematol. 2002;75:19–24.CrossRefPubMed Sugimoto M, Miyata S. Functional property under flowing blood. Int J Hematol. 2002;75:19–24.CrossRefPubMed
30.
Zurück zum Zitat Giessen PLA, Rauch U, Bohmann B, Kling D, Roqué M, Fallon JT, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311–5.CrossRef Giessen PLA, Rauch U, Bohmann B, Kling D, Roqué M, Fallon JT, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311–5.CrossRef
31.
Zurück zum Zitat Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex vivo thrombi. Thromb Haemost. 2002;88:822–6.PubMed Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex vivo thrombi. Thromb Haemost. 2002;88:822–6.PubMed
32.
Zurück zum Zitat Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr, et al. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost. 2009;101:748–54.PubMedPubMedCentral Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr, et al. Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost. 2009;101:748–54.PubMedPubMedCentral
33.
Zurück zum Zitat Ikezoe T. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol. 2014;100:27–37.CrossRefPubMed Ikezoe T. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. Int J Hematol. 2014;100:27–37.CrossRefPubMed
34.
Zurück zum Zitat Orvim U, Roald HE, Stephens RW, Roos N, Sakariassen KS. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb Vasc Biol. 1994;14:1976–83.CrossRef Orvim U, Roald HE, Stephens RW, Roos N, Sakariassen KS. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb Vasc Biol. 1994;14:1976–83.CrossRef
35.
Zurück zum Zitat De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem. 1994;269:6478–84.PubMed De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem. 1994;269:6478–84.PubMed
36.
Zurück zum Zitat Kahn ML. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;6:879–87.CrossRef Kahn ML. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;6:879–87.CrossRef
37.
Zurück zum Zitat Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002;22:1381–9.CrossRefPubMed Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol. 2002;22:1381–9.CrossRefPubMed
38.
Zurück zum Zitat Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585–98.CrossRefPubMedPubMedCentral Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585–98.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Steppich BA, Seitz I, Busch G, Stein A, Ott I. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thromb Haemost. 2008;100:1068–75.PubMed Steppich BA, Seitz I, Busch G, Stein A, Ott I. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thromb Haemost. 2008;100:1068–75.PubMed
40.
Zurück zum Zitat Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16:887–96.CrossRefPubMed Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16:887–96.CrossRefPubMed
41.
Zurück zum Zitat Goel MS, Diamond SL. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem. 2003;278:9458–63.CrossRefPubMed Goel MS, Diamond SL. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem. 2003;278:9458–63.CrossRefPubMed
42.
Zurück zum Zitat Doi M, Matsui H, Takeda H, Saito Y, Takeda M, Matsunari Y, et al. ADAMTS13 safeguards the myocardium in a mouse model of myocardial infarction. Thromb Haemost. 2012;108:1236–8.CrossRefPubMed Doi M, Matsui H, Takeda H, Saito Y, Takeda M, Matsunari Y, et al. ADAMTS13 safeguards the myocardium in a mouse model of myocardial infarction. Thromb Haemost. 2012;108:1236–8.CrossRefPubMed
43.
Zurück zum Zitat De Meyer SF, Savchenco AS, Haas MS, Schatzberg D, Carroll MC, Schiviz A, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. 2012;120:5217–23.CrossRefPubMedPubMedCentral De Meyer SF, Savchenco AS, Haas MS, Schatzberg D, Carroll MC, Schiviz A, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. 2012;120:5217–23.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Kasuda S, Matsui H, Ono S, Matsunari Y, Nishio K, Shima M, et al. Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture. Haematologica. 2016;101:e52–4.CrossRefPubMedPubMedCentral Kasuda S, Matsui H, Ono S, Matsunari Y, Nishio K, Shima M, et al. Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture. Haematologica. 2016;101:e52–4.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065–74.CrossRefPubMedPubMedCentral Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205:2065–74.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114:2367–74.CrossRefPubMed Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114:2367–74.CrossRefPubMed
Metadaten
Titel
Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions
verfasst von
Yasunori Matsunari
Mitsuhiko Sugimoto
Masaaki Doi
Hideto Matsui
Masahiko Kawaguchi
Publikationsdatum
25.08.2016
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 6/2016
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-2086-z

Weitere Artikel der Ausgabe 6/2016

International Journal of Hematology 6/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.